Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

Despite advances in conventional chemotherapy, surgical techniques, and radiation, outcomes for patients with relapsed, refractory, or metastatic soft tissue sarcomas are dismal. Survivors often suffer from lasting morbidity from current treatments. New targeted therapies with less toxicity, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ring, Eric K., Li, Rong, Moore, Blake P., Nan, Li, Kelly, Virginia M., Han, Xiaosi, Beierle, Elizabeth A., Markert, James M., Leavenworth, Jianmei W., Gillespie, G. Yancey, Friedman, Gregory K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633864/
https://www.ncbi.nlm.nih.gov/pubmed/29034313
http://dx.doi.org/10.1016/j.omto.2017.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633864/
https://www.ncbi.nlm.nih.gov/pubmed/29034313
http://dx.doi.org/10.1016/j.omto.2017.09.003

Ejemplares similares